Dermira (NASDAQ: DERM) reported Q1 EPS of ($0.18), $0.08 worse than the analyst estimate of ($0.10). Revenue for the quarter came in at $13.1 million versus the consensus estimate of $12.06 million.

For earnings history and earnings-related data on Dermira (DERM) click here.